- Previous Close
1.8800 - Open
1.8700 - Bid --
- Ask --
- Day's Range
1.8000 - 1.8800 - 52 Week Range
1.6600 - 3.2900 - Volume
370,742 - Avg. Volume
514,496 - Market Cap (intraday)
154.763M - Beta (5Y Monthly) 1.54
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3000 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.50
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
www.stereotaxis.comRecent News: STXS
View MorePerformance Overview: STXS
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STXS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STXS
View MoreValuation Measures
Market Cap
154.76M
Enterprise Value
153.90M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.70
Price/Book (mrq)
25.45
Enterprise Value/Revenue
5.72
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-89.33%
Return on Assets (ttm)
-31.72%
Return on Equity (ttm)
-144.19%
Revenue (ttm)
26.92M
Net Income Avi to Common (ttm)
-25.35M
Diluted EPS (ttm)
-0.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
12.22M
Total Debt/Equity (mrq)
52.54%
Levered Free Cash Flow (ttm)
4.58M